Colony Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,203
Closed -$285K 725
2019
Q1
$285K Buy
3,203
+60
+2% +$5.34K 0.01% 520
2018
Q4
$268K Buy
+3,143
New +$268K 0.01% 422